NorDiag enters distribution and collaboration agreement with Molzym
NorDiag has also entered into a collaboration agreement with Molzym, primarily with the purpose of integrating NorDiag’s magnetic bead based sample preparation chemistry and low throughput automation platform with Molzym’s molecular diagnostic products among others their SepsiTest™.
“We have chosen NorDiag due to their geographic presence, competence and position in the clinical diagnostic market”, says Molzym CEO Jan Detmers.
“Growing revenues by taking in complementary products is a key element in our strategy going forward and the agreements with Molzym will be an important contributor in increasing volumes. We also intend to offer an OEM agreement for NorDiag’s products to Molzym, which will open for cross-sales and further increase revenues” says NorDiag CEO Mårten Wigstøl.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.